Detalhe da pesquisa
1.
Efficacy and safety of molnupiravir for the treatment of SARS-CoV-2 infection: a systematic review and meta-analysis.
J Antimicrob Chemother
; 78(7): 1586-1598, 2023 07 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37170886
2.
Immune response to mRNA-based COVID-19 booster vaccination in people living with HIV.
HIV Med
; 24(7): 785-793, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-36883641
3.
Key summary of German national treatment guidance for hospitalized COVID-19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021).
Infection
; 50(1): 93-106, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-34228347
4.
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.
Cochrane Database Syst Rev
; 6: CD014945, 2022 06 17.
Artigo
Inglês
| MEDLINE | ID: mdl-35713300
5.
National medical specialty guidelines of HIV indicator conditions in Europe lack adequate HIV testing recommendations: a systematic guideline review.
Euro Surveill
; 27(48)2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36695464
6.
Remdesivir against COVID-19 and Other Viral Diseases.
Clin Microbiol Rev
; 34(1)2020 12 16.
Artigo
Inglês
| MEDLINE | ID: mdl-33055231
7.
[Antiviral drugs : Potent agents, promising therapies for COVID19 and therapeutic limitations]. / Antivirale Medikamente : Potente Wirkstoffe, Hoffnungsträger bei COVID19 und therapeutische Grenzen.
Internist (Berl)
; 63(1): 118-128, 2022 Jan.
Artigo
Alemão
| MEDLINE | ID: mdl-34988607
8.
Plasma interferon-γ-inducible protein 10 (IP-10) levels correlate with disease severity and paradoxical reactions in extrapulmonary tuberculosis.
Infection
; 49(3): 437-445, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-33140838
9.
Rapid response infrastructure for pandemic preparedness in a tertiary care hospital: lessons learned from the COVID-19 outbreak in Cologne, Germany, February to March 2020.
Euro Surveill
; 25(21)2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32489176
10.
Correction to: Key summary of German national treatment guidance for hospitalized COVID19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021).
Infection
; 50(1): 107-108, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-34414563
11.
Pharmacokinetics of remdesivir in a COVID-19 patient with end-stage renal disease on intermittent haemodialysis.
J Antimicrob Chemother
; 76(3): 825-827, 2021 02 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33251541
12.
DGI recommendations for COVID-19 pharmacotherapy.
Infection
; 49(2): 369-370, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33074366
13.
Extremely Low Hit Rate in a Diverse Chemical Drug Screen Targeting Mycobacterium abscessus.
Antimicrob Agents Chemother
; 63(11)2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31427298
14.
Longitudinal fluctuations of common antimicrobial resistance genes in the gut microbiomes of healthy Dutch individuals.
Int J Antimicrob Agents
; 61(3): 106716, 2023 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-36640847
15.
Recommendations for the Outpatient Drug Treatment of Patients With COVID-19.
Dtsch Arztebl Int
; 119(19): 342-349, 2022 05 13.
Artigo
Inglês
| MEDLINE | ID: mdl-35506263
16.
Remdesivir for the treatment of patients hospitalized with COVID-19 receiving supplemental oxygen: a targeted literature review and meta-analysis.
Sci Rep
; 12(1): 9622, 2022 06 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35688854
17.
Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS-CoV-2 mRNA vaccination.
EMBO Mol Med
; 14(8): e15888, 2022 08 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35785445
18.
Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trial.
Lancet Microbe
; 3(3): e203-e214, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35544074
19.
Clinical Practice Guideline: Recommendations on the In-hospital Treatment of Patients with COVID-19.
Dtsch Arztebl Int
; 118(50): 865-871, 2021 12 27.
Artigo
Inglês
| MEDLINE | ID: mdl-34789365
20.
A comparative analysis of remdesivir and other repurposed antivirals against SARS-CoV-2.
EMBO Mol Med
; 13(1): e13105, 2021 01 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33015938